Calvo Elected for Second Term at EMA

September 22, 2016
Philip Ward

Philip Ward is ACT's European editor, phone +44 1244 538583, philipward1@btconnect.com

Dr. Gonzalo Calvo has been re-elected by the Healthcare Professionals’ Working Party (HCPWP) of the European Medicines Agency (EMA) as its co-chair.

The Healthcare Professionals' Working Party (HCPWP) of the European Medicines Agency (EMA) has re-elected Dr. Gonzalo Calvo as its co-chair.

Calvo, a physician and consultant in clinical pharmacology from Barcelona, Spain, has extensive experience in medicines regulation, including nearly 10 years as a member of EMA’s Committee for Medicinal Products for Human Use (CHMP).

“My aim is to consolidate the work initiated and open new paths to strengthen the role and impact of healthcare professionals in regulatory activities, securing fast and safe access to new medicines,” said Calvo. “Close collaboration with the patients and consumers’ working group has been instrumental for the progress of HCPWP work. I do not see any other way forward than enhancing our interaction with patients and consumers.”

Together with Isabelle Moulon, Head of the Public Engagement Department at EMA, he will co-chair HCPWP for the next three years.

No decision was reached, however, on the new co-chair of the Patients' and Consumers' Working Party (PCWP).

The main role of the PCWP and the HCPWP is to provide recommendations to EMA and its scientific committees on all matters of interest to either patients and consumers or healthcare professionals in relation to medicines, as well as to monitor interactions between the agency and patients, consumers and healthcare professionals.

Related Content:

News